Cardiac RadiothErapy for VEntricular Tachycardia II
Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular
| Condition(s) | Ventricular Tachycardia (VT) |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia. |
| Who can participate | Inclusion Criteria: * Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion * Ability to give a written informed consent and willingness to return for follow-up Exclusion Criteria: * Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy \< 6 months in the absence of VT * Any condition that is deemed a contraindication in the judgment of the investigators |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven |
| Locations | Leuven, Belgium |
| Start date | 2025-01-01 |
| NCT ID | NCT06744530 |
| Official listing | https://clinicaltrials.gov/study/NCT06744530 |